Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  European Journal of Pharmacology

• Publication date

  1984-03-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(84)90284-XPMID 6144557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats.

  1984cited by this paper
• alpha-Adrenergic blocking action of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats.

  1983cited by this paper
• Cardiovascular Effects of Antihypertensive Polar and Neutral Renomedullary Lipids

  1983cited by this paper
• Cardiovascular effects of antihypertensive renomedullary lipids (APRL and ANRL).

  1983cited by this paper
• α-Adrenergic Blocking Action of 1-O-Hexadecyl-2-0-Acetyl-sn-Glycero-3-Phosphocholine in Rats

  1983cited by this paper
• Blockade of alpha-adrenergic receptors by analogues of phosphatidylcholine.

  1982cited by this paper
• Cardiovascular and sympathetic effects of l-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious SHR and WKY rats.

  1982cited by this paper
• Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine.

  1982cited by this paper
• Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism.

  1982cited by this paper
• Potent hypotensive activity of 1-O-hexadecyl-2-O-acetyl-SN-glycero-3-phosphocholine in spontaneously hypertensive rat.

  1982cited by this paper
• Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla.

  1981cited by this paper
• Alkyl Ether Analogs of Phosphatidylcholine Are Orally Active in Hypertensive Rabbits

  1981cited by this paper
• Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine.

  1981cited by this paper
• Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture.

  1980cited by this paper
• Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine.

  1980cited by this paper
• Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

  1980cited by this paper
• Antihypertensive Functions of the Kidney

  1980cited by this paper
• Pressor response to 5-hydroxytryptamine, norepinephrine and KCi in the perfused hindquarter preparation from the spontaneously hypertensive rat.

  1980cited by this paper
• Antihypertensive Polar Renomedullary Lipid, A Semisynthetic Vasodilator

  1979cited by this paper
• Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

  1979cited by this paper
• Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes

  1979cited by this paper
• ROLE OF PLATELETS IN ASPIRIN‐SENSITIVE BRONCHOCONSTRICTION IN THE GUINEA‐PIG; INTERACTIONS WITH SALICYLIC ACID

  1978cited by this paper
• Local specificity in responses of canine coronary vessels to oxygen deficiency and antianginal drugs.

  1977cited by this paper
• LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS

  1972cited by this paper
• Isolation of a phospholipid renin inhibitor from kidney.

  1967cited by this paper
• Actions of some peptides on bronchial muscle.

  1962cited by this paper

• Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis.

  2006cites this paper
• VASCULAR OCCLUSION Platelets , endothelium , and vasospasm

  2005cites this paper
• Endothelium-dependent relaxant action of platelet activating factor in the rat mesenteric artery

  2004cites this paper
• Phospholipase A(2) isoforms: a perspective.

  2003cites this paper
• Phospholipase A2 isoforms: a perspective

  2003cites this paper
• Role of platelet-activating factor in cardiovascular pathophysiology.

  2000cites this paper
• Platelet-activating factor acetylhydrolases in health and disease.

  2000cites this paper
• Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.

  1999cites this paper
• A Mutation in Plasma Platelet-activating Factor Acetylhydrolase (Val279Phe) Is a Genetic Risk Factor for Cerebral Hemorrhage but not for Hypertension

  1998cites this paper
• The acute increases in vasomotor tone and blood pressure induced by carotid artery occlusion are modulated by platelet-activating factor (PAF) independently of nitric oxide release.

  1997cites this paper
• Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors.

  1997cites this paper
• A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke.

  1997cites this paper
• Involvement of nitric oxide and eicosanoids in platelet‐activating factor‐induced haemodynamic and haematological effects in dogs

  1996cites this paper
• Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs.

  1996cites this paper
• Role of platelet-activating factor antagonism in haemorrhagic shock in pigs.

  1995cites this paper
• Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.

  1994cites this paper
• Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.

  1994cites this paper
• 8 – Biological Properties of Platelet-Activating Factor

  1994cites this paper
• Mediators of the hypotensive response to increased renal perfusion in rabbits.

  1993cites this paper
• Cardiovascular effects of Acanthaster planci venom in the rat: possible involvement of PAF in its hypotensive effect.

  1992cites this paper
• Platelet Activating Factor: Rationale for the Use of PAF-Antagonists in Sepsis

  1992cites this paper
• Putative mechanism of hypotensive action of platelet-activating factor in dogs.

  1992cites this paper
• Involvement of nitric oxide pathway in the PAF‐induced relaxation of rat thoracic aorta

  1992cites this paper
• Effects of Platelet Activating Factor on Contractions and Ca Influx Induced by Noradrenaline and Potassium in Rat Rubbed and Intact Aorta. Comparison with Its Hypotensive Effect in Anaesthetized Normotensive Rats

  1992cites this paper
• Reversal of experimental renovascular hypertension.

  1991cites this paper
• Attenuation of depressor response induced by platelet activating factor and acetylcholine in streptozotocin-induced diabetic rats.

  1991cites this paper
• A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia.

  1991cites this paper
• Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.

  1991cites this paper
• Platelet activating factor and the circulation.

  1991cites this paper
• Platelet-activating factor in cardiovascular stress situations

  1991cites this paper
• Cardiovascular effects of platelet-activating factor

  1991cites this paper
• Platelet activating factor‐induced shock and intestinal necrosis in the rat: Role of endogenous platelet‐activating factor and effect of saline infusion

  1991cites this paper
• A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.

  1990cites this paper
• The Pharmacology of microbial Modulation in the Induction and Expression of Immune Reactivities

  1990cites this paper
• PROLONGED SURVIVAL OF RENAL TRANSPLANTS IN NONIMMUNIZED AND HYPERIMMUNIZED RATS RECEIVING A PLATELET‐ACTIVATING FACTOR ANTAGONIST

  1990cites this paper
• Release of a neutrophil‐derived vascoconstrictor agent which augments platelet‐induced contractions of blood vessels in vitro

  1990cites this paper
• Effect of platelet-activating factor (PAF) on sodium calcium exchange in cardiac sarcolemmal vesicles

  1990cites this paper
• [Platelet activating factor--a biologically active phospholipid].

  1990cites this paper
• Immunopharmacology Reviews

  1990cites this paper
• Reproducible vasodilatation by platelet-activating factor in blood- and Krebs-perfused rat kidneys is albumin-dependent.

  1990cites this paper
• Endothelium‐dependent vasodilator effects of platelet activating factor on rat resistance vessels

  1989cites this paper
• Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2.

  1989cites this paper
• Interaction of platelet‐activating factor with endothelial and vascular smooth muscle cells in coculture

  1989cites this paper
• Mechanisms of hypotension produced by platelet-activating factor.

  1989cites this paper
• Platelet-activating factor (PAF) antagonistic actions of two new analogs of tetrahydrofurans.

  1989cites this paper
• INHIBITION OF VASOCONSTRICTION BY PLATELET ACTIVATING FACTOR IN THE IN SITU BLOOD PERFUSED RAT MESENTERY

  1989cites this paper
• PAF Antagonists as Potential Therapeutic Agents in Cardiac Anaphylaxis and Myocardial Ischemia

  1989cites this paper
• Effects of BN 52063 and other agents inhibiting platelet‐activating factor‐induced contractile responses in rat portal vein

  1988cites this paper
• Platelet‐activating factor‐induced cellular and pathophysiological responses in the cardiovascular system

  1988cites this paper
• Platelets and Endothelium-Dependent Responses

  1988cites this paper
• Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs.

  1988cites this paper
• Interaction of the formed elements of blood with the coronary vasculature in vivo.

  1987cites this paper
• Potentiation by bovine serum albumin (BSA) of endothelium-dependent vasodilator response to acetyl glyceryl ether phosphorylcholine (AGEPC).

  1987cites this paper
• Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog.

  1987cites this paper
• Platelet-activating factor antagonists.

  1987cites this paper
• L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney.

  1987cites this paper
• Mechanisms of Circulatory Collapse Induced by PAF-Acether

  1987cites this paper
• Hemodynamic effects of PAF-acether on the dog kidney.

  1987cites this paper
• Verwendung eines 2-Aryl-3,4-diaza-bicyclo[4.n.O]alken-(2)-ons-(5) zur Herstellung eines Mittels zur Behandlung der Herzinsuffizienz

  1986cites this paper
• Inhibition of PAF-lnduced Systemic Responses in the Rat, Guinea Pig, Dog and Primate by the Receptor Antagonist SRI 63-441

  1986cites this paper
• Hemodynamic effects of platelet activating factor in the dog kidney in vivo.

  1986cites this paper
• Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine

  1986cites this paper
• Specific antagonists of platelet activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.

  1986cites this paper
• Studies of platelet activating factor (PAF) antagonists from microbial products. II. Pharmacological studies of FR-49175 in animal models.

  1986cites this paper
• Platelet-activating factor and the kidney.

  1986cites this paper
• Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells.

  1986cites this paper
• Modulation of vascular smooth muscle contraction by the endothelium.

  1986cites this paper
• Platelet activating factor and inflammation in atherogenesis: Targets for drug development

  1986cites this paper
• Platelet‐Activating Factor and the Release of a Platelet‐Derived Coronary Artery Vasodilator Substance in the Canine

  1986cites this paper
• Platelet-activating factor causes pulmonary vasodilation in the rat.

  1986cites this paper
• Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist.

  1986cites this paper
• PLATELETS, ENDOTHELIUM AND VASOSPASM

  1985cites this paper
• Evidence for a Direct Effect on Vascular Permeability of Platelet-Activating Factor Induced Hemoconcentration in the Guinea Pig

  1985cites this paper
• Cardiac output and peripheral vascular resistance during intravenous infusion of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious normotensive and spontaneously hypertensive rats.

  1985cites this paper
• Chapter 20. Platelet-Activating Factor: Multifaceted Biochemical and Physiological Mediator

  1985cites this paper